Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

During the Trading Day
72.31 +0.05 / +0.07%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
72.31 0.00 / 0.00%
 
Volume: 12.1K

Today’s Trading

Previous close72.26
Today’s open73.57
Day’s range71.71 - 76.33
Volume3,464,160
Average volume (3 months)2,113,264
Market cap$13.4B
Dividend yield--
Data as of 4:00pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+33.91%
Earnings growth (next 5 years)+199.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...-1.22-2.34%
BMRNBiomarin Pharmaceuti...+1.91+2.93%
VRTXVertex Pharmaceutica...+1.59+1.98%
JAZZJazz Pharmaceuticals...-0.21-0.18%
Data as of 4:00pm ET, 02/10/2016

Financials

Next reporting dateFebruary 11, 2016
EPS forecast (this quarter)$0.10
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Partner Offers